
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4838B8AEEF72305838B002DFEEF6A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="lwwopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Clinical Gastroenterology">
<meta name="citation_title" content="High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease">
<meta name="citation_author" content="Yash Hegde">
<meta name="citation_author_institution" content="Department of Medicine">
<meta name="citation_author" content="Sarah K Lazarus">
<meta name="citation_author_institution" content="Department of Medicine, Hennepin Healthcare, Minneapolis, MN">
<meta name="citation_author" content="Francis A Farraye">
<meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Mayo Clinic, Jacksonville, FL">
<meta name="citation_author" content="Fauzia Hollnagel">
<meta name="citation_author_institution" content="Department of Medicine, Biostatistics">
<meta name="citation_author" content="Mary S Hayney">
<meta name="citation_author_institution" content="University of Wisconsin-Madison School of Pharmacy">
<meta name="citation_author" content="Freddy Caldera">
<meta name="citation_author_institution" content="Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine and Public Health, University of Wisconsin, Madison, WI">
<meta name="citation_publication_date" content="2024 Nov 6">
<meta name="citation_volume" content="59">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="773">
<meta name="citation_doi" content="10.1097/MCG.0000000000002098">
<meta name="citation_pmid" content="40424081">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/pdf/mcg-59-773.pdf">
<meta name="description" content="Patients with inflammatory bowel disease (IBD) are commonly treated with immunosuppressive therapies that increase the risk for infections, including hepatitis B (HepB) virus. Adult patients with IBD have suboptimal seroprotection rates after ...">
<meta name="og:title" content="High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Patients with inflammatory bowel disease (IBD) are commonly treated with immunosuppressive therapies that increase the risk for infections, including hepatitis B (HepB) virus. Adult patients with IBD have suboptimal seroprotection rates after ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12329805">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1097/MCG.0000000000002098"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/mcg-59-773.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12329805%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12329805/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12329805/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-lwwopen.png" alt="Lippincott Open Access logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Lippincott Open Access" title="Link to Lippincott Open Access" shape="default" href="https://doi.org/10.1097/MCG.0000000000002098" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Clin Gastroenterol</button></div>. 2024 Nov 6;59(8):773–779. doi: <a href="https://doi.org/10.1097/MCG.0000000000002098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1097/MCG.0000000000002098</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Clin%20Gastroenterol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Clin%20Gastroenterol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Clin%20Gastroenterol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Clin%20Gastroenterol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hegde%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yash Hegde</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Yash Hegde</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>*</sup>Department of Medicine</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hegde%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yash Hegde</span></a>
</div>
</div>
<sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lazarus%20SK%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Sarah K Lazarus</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Sarah K Lazarus</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>†</sup>Department of Medicine, Hennepin Healthcare, Minneapolis, MN</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lazarus%20SK%22%5BAuthor%5D" class="usa-link"><span class="name western">Sarah K Lazarus</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Farraye%20FA%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Francis A Farraye</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Francis A Farraye</span>, <span class="degrees">MD, MSc</span>
</h3>
<div class="p">
<sup>‡</sup>Department of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Mayo Clinic, Jacksonville, FL</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Farraye%20FA%22%5BAuthor%5D" class="usa-link"><span class="name western">Francis A Farraye</span></a>
</div>
</div>
<sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollnagel%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Fauzia Hollnagel</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Fauzia Hollnagel</span>, <span class="degrees">MPH</span>
</h3>
<div class="p">
<sup>§</sup>Department of Medicine, Biostatistics</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollnagel%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fauzia Hollnagel</span></a>
</div>
</div>
<sup>§</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hayney%20MS%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mary S Hayney</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Mary S Hayney</span>, <span class="degrees">PharmD, MPH</span>
</h3>
<div class="p">
<sup>∥</sup>University of Wisconsin-Madison School of Pharmacy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hayney%20MS%22%5BAuthor%5D" class="usa-link"><span class="name western">Mary S Hayney</span></a>
</div>
</div>
<sup>∥</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caldera%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Freddy Caldera</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Freddy Caldera</span>, <span class="degrees">DO, PhD</span>
</h3>
<div class="p">
<sup>¶</sup>Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine and Public Health, University of Wisconsin, Madison, WI</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caldera%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Freddy Caldera</span></a>
</div>
</div>
<sup>¶,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>*</sup>Department of Medicine</div>
<div id="aff2">
<sup>§</sup>Department of Medicine, Biostatistics</div>
<div id="aff3">
<sup>∥</sup>University of Wisconsin-Madison School of Pharmacy</div>
<div id="aff4">
<sup>¶</sup>Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine and Public Health, University of Wisconsin, Madison, WI</div>
<div id="aff5">
<sup>†</sup>Department of Medicine, Hennepin Healthcare, Minneapolis, MN</div>
<div id="aff6">
<sup>‡</sup>Department of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Mayo Clinic, Jacksonville, FL</div>
<div class="author-notes p">
<div class="fn" id="corresp1">
<sup>✉</sup><p class="display-inline">Address correspondence to: Freddy Caldera, DO, PhD, 1685 Highland Avenue, Madison, WI 53705-2281 (e-mail: <span>fcaldera@medicine.wisc.edu</span>).</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Jun 1; Accepted 2024 Oct 6; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</a>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12329805  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40424081/" class="usa-link">40424081</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective:</h3>
<p>Patients with inflammatory bowel disease (IBD) are commonly treated with immunosuppressive therapies that increase the risk for infections, including hepatitis B (HepB) virus. Adult patients with IBD have suboptimal seroprotection rates after vaccination with a 3-dose recombinant recombinant HepB vaccine. Heplisav-B is an adjuvanted 2-dose HepB series that is more immunogenic in the general adult population. Herein, we evaluated the immunogenicity of Heplisav-B in adult patients with IBD.</p></section><section id="sec2"><h3 class="pmc_sec_title">Patients and Methods:</h3>
<p>We conducted a prospective observational study of adult patients with IBD who were not seroprotected to HepB virus and received a Heplisav-B series with postimmunization HepB surface antibody (anti-HBs) serologic testing. Postimmunization anti-HBs ≥10 IU/mL was considered seroprotection. The primary outcome was the rate of seroprotection. Secondary outcomes were rates of seroprotection in different age groups, those on immunosuppressive therapy, and previous HepB vaccine nonresponders using a univariate analysis.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>Eighty-five patients met the inclusion criteria with the majority (72%) achieving seroprotection with a median anti-HBs level of 48.7 IU/mL and 28 patients (33%) having an anti-HBs level &gt;100 IU/mL. Those on immunosuppressive therapy [49 (58%), 18 nonresponders, odds ratio: 0.34, 95% CI: 0.12-0.99] and primary nonresponders to a previous HepB series [22 (26%), 11 nonresponders, odds ratio: 0.26, 95% CI: 0.09-0.73] were less likely to achieve seroprotection. Seven patients who did not respond received a third dose of Heplisav-B, and 2 achieved seroprotection.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions:</h3>
<p>Heplisav-B achieved higher rates of seroprotection than those seen with 3-dose recombinant HepB vaccines in patients with IBD and may be the preferred option.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Key Words:</strong> inflammatory bowel disease, Heplisav-B, hepatitis B virus</p></section></section><hr class="headless">
<p>Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are a group of chronic inflammatory diseases involving the gastrointestinal tract. Advances in treatment options include small molecules, anti-tumor necrosis factor (TNF) agents, and non-TNF biologics.<sup><a href="#R1" class="usa-link" aria-describedby="R1">1</a>,<a href="#R2" class="usa-link" aria-describedby="R2">2</a></sup> These advanced therapies have higher rates of clinical remission than conventional therapy but can result in hepatitis B virus (HBV) reactivation.<sup><a href="#R3" class="usa-link" aria-describedby="R3">3</a></sup>
</p>
<p>HBV infection and reactivation can occur in the context of immunosuppression, which has been reported as being associated with considerable morbidity and mortality.<sup><a href="#R4" class="usa-link" aria-describedby="R4">4</a>,<a href="#R5" class="usa-link" aria-describedby="R5">5</a></sup> Given this risk it is recommended that patients with IBD are evaluated for an HBV infection and those not previously vaccinated receive a hepatitis B (HepB) vaccine series.<sup><a href="#R6" class="usa-link" aria-describedby="R6">6</a></sup> Furthermore, preventative care guidelines recommend that they have HepB surface antibody (anti-HBs) levels checked 1 to 3 months after completion of the vaccine series to ensure seroprotection (anti-HBs ≥10 IU/L) was achieved due to suboptimal seroconversion rates in immunosuppressed patients with IBD.<sup><a href="#R7" class="usa-link" aria-describedby="R7">7</a>–<a href="#R9" class="usa-link" aria-describedby="R9">9</a></sup> A systematic review and meta-analysis evaluating seroconversion rates to HepB among patients with IBD demonstrated a pooled proportion of adequate immune response of 64%.<sup><a href="#R10" class="usa-link" aria-describedby="R10">10</a></sup> In addition, it has been shown that patients on anti-TNF agents are less likely to have protective anti-HBs after vaccination.<sup><a href="#R11" class="usa-link" aria-describedby="R11">11</a></sup> Currently, the most commonly used schedule for HepB vaccination in patients with IBD is a 3-dose recombinant series with an aluminum hydroxide adjuvant.<sup><a href="#R12" class="usa-link" aria-describedby="R12">12</a></sup> Despite this vaccine being immunogenic in over 90% of the general population, it has suboptimal response rates in patients who are immunocompromised, older than 40 years of age, and those with chronic medical conditions such as liver cirrhosis, diabetes mellitus, and chronic kidney disease.<sup><a href="#R13" class="usa-link" aria-describedby="R13">13</a>–<a href="#R16" class="usa-link" aria-describedby="R16">16</a></sup>
</p>
<p>Heplisav-B [HepB- cytidine phospho-guanosine (CpG)] is a 2-dose adjuvanted recombinant HepB series approved by the U.S. Food and Drug Administration in 2017 with a new cytosine phosphoguanine adjuvant that is more immunogenic in the general adult population and in those with chronic kidney disease or diabetes mellitus.<sup><a href="#R17" class="usa-link" aria-describedby="R17">17</a>,<a href="#R18" class="usa-link" aria-describedby="R18">18</a></sup> It was subsequently approved by the European Medicines Agency for use in Europe in February 2021 and by the Medicines and Healthcare products Regulatory Agency for use in the UK in February 2023. In February 2018, the Advisory Committee on Immunization Practices recommended HepB-CpG to prevent HBV infection in adults aged 19 years and older. In a systematic review analyzing 4 randomized controlled trials involving general adult subjects, seroprotective anti-HB levels were reached in 90% to 100% of participants receiving HepB-CpG, compared with 70.5% to 90.2% of participants receiving 3-dose recombinant HepB with aluminum adjuvant series.<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a></sup> There is limited data on the immunogenicity of HepB-CpG in patients with IBD or other immunosuppressed populations. A retrospective observational study demonstrated a high rate of seroprotection (78.3%) in patients with IBD vaccinated with HepB-CpG, but it was limited due to a challenge dose to assess an anamnestic response not being provided, a complete 2-dose series not being given to a large portion (32%) of patients, and its retrospective nature.<sup><a href="#R20" class="usa-link" aria-describedby="R20">20</a></sup> In addition, a recent study showed that most patients with IBD who received a 3-dose HepB series have an anamnestic response and sustained seroprotection to HBV despite prolonged exposure to immunosuppressive therapy.<sup><a href="#R21" class="usa-link" aria-describedby="R21">21</a></sup> The primary aim of this prospective observational study was to determine the rates of seroprotection after completion of HepB-CpG in patients with IBD. We hypothesized that we would see higher rates of seroconversion compared with historical rates, given that HepB-CpG has superior immunogenicity in the general population.</p>
<section id="sec5"><h2 class="pmc_sec_title">PATIENTS AND METHODS</h2>
<p>This single-center, observational, and prospective study was conducted between November 2019 and May 2023 at the University of Wisconsin, Madison. Participants were eligible if they met the following inclusion criteria: (1) a history of chronic (&gt;3 mo) UC or CD diagnosed and documented by standard clinical, radiographic, endoscopic, and histopathologic criteria, (2) age 18 years or older, (3) had been on stable IBD therapy for at least 3 months, (4) did not respond to a challenge dose of HepB if they had previously completed a HepB vaccine series and had an anti-HB level &lt;10 IU/mL, (5) completion of 2 doses of the HepB series HepB-CpG recombinant, adjuvanted HepB recorded in the Wisconsin Immunization Registry (WIR), (6) and had an anti-HB level measured 4 to 8 weeks postimmunization, which was used to establish seroprotection against HBV. Patients were not eligible for this study and were excluded if they: (1) did not complete the 2-dose HepB series HepB-CpG, (2) did not have an anti-HBs level measured postimmunization, (3) had an autoimmune condition other than IBD that required immunosuppressive therapy, and (4) were a member of a vulnerable group that included those who were pregnant, lacked decision-making capacity, and were non-English speaking.</p>
<p>Patients with IBD who met the inclusion and exclusion criteria underwent venipuncture during a clinical visit to measure anti-HB levels. Immunization, medical, and medication histories were reviewed. Anti-HB levels were measured 4 to 8 weeks after the second dose, and anti-HB levels ≥10 IU/mL were considered to be seroprotective. If they were not determined to be seroprotected after the full 2-dose HepB-CpG HepB series, a third dose was recommended, with repeated anti-HB levels measured to assess seroprotection.</p>
<p>All data were manually extracted from electronic medical records and included baseline patient demographics, age at the time of vaccination, diagnosis of UC or CD, length of time since IBD diagnosis, IBD therapy at the time of vaccination, number of previous HepB series and doses, number of HepB-CpG vaccination doses, and postvaccination anti-HBs levels. IBD therapy at the time of vaccination was separated into the following categories: (1) no therapy or aminosalicylate monotherapy, (2) vedolizumab monotherapy, (3) thiopurine monotherapy (azathioprine or 6-mercaptopurine), (4) anti-TNF monotherapy (maintenance adalimumab, golimumab, infliximab, or certolizumab), (5) anti-TNF combination therapy (anti-TNF therapy as described previously with thiopurine or methotrexate), (6) ustekinumab therapy (ustekinumab monotherapy or combination therapy with thiopurine or methotrexate), and (7) tofacitinib therapy. Treatment with systemic corticosteroids in conjunction with other IBD therapy during vaccination was also considered and was recorded for doses equal to ≥20 mg of prednisone daily for at least 1 week at the time of the first vaccination. We defined patients on thiopurine monotherapy, anti-TNF monotherapy, anti-TNF combination therapy, ustekinumab therapy, tofacitinib therapy, or corticosteroids at the time of vaccination as being systemically immunosuppressed. Vedolizumab was not considered in this group since previous studies have shown it does not appear to influence vaccine response.<sup><a href="#R22" class="usa-link" aria-describedby="R22">22</a>–<a href="#R24" class="usa-link" aria-describedby="R24">24</a></sup>
</p>
<p>The primary outcome measured in this study was the rate of seroprotection in adult patients with IBD after vaccination with HepB-CpG. The secondary outcomes of our study included determining predictors of seroprotection by comparing those who received systemic immunosuppressive therapy and those who did not, seroprotection rates between age groups, seroprotection rates between those who received a previous HepB vaccination series before HepB-CpG and those who did not, and seroprotection rates in those who needed a third dose of HepB-CpG after failing a 2-dose series and those who did not.</p>
<section id="sec6"><h3 class="pmc_sec_title">Wisconsin Immunization Registry</h3>
<p>The WIR is a confidential, statewide immunization information system designed to share immunization histories of state residents of all ages with the objective of decreasing vaccine-preventable illnesses.<sup><a href="#R25" class="usa-link" aria-describedby="R25">25</a></sup> It is included in the University of Wisconsin Hospital and Clinics’ electronic medical record. It was created in May 2000 by the Wisconsin Divisions of Public Health and Health Care Access and Accountability. It includes client demographic data for all Wisconsin births since 1995 from the Wisconsin Divisions of Public Health Office of Health Informatics.<sup><a href="#R26" class="usa-link" aria-describedby="R26">26</a></sup> New client demographics and immunization information are added through private and public health care providers in the state. In a recent study evaluating the completeness and accuracy of the WIR, it was found that 98% of patients in the study had WIR client records and 97% of their vaccinations were documented in the registry supporting its validity.<sup><a href="#R25" class="usa-link" aria-describedby="R25">25</a></sup>
</p></section><section id="sec7"><h3 class="pmc_sec_title">Statistical Analyses</h3>
<p>We compared all variables using either the χ<sup>2</sup> or Fisher exact test. Age was expressed as mean and SD for normally distributed data. As the quantitative HepB antibody variable was non-normally distributed, we summarized the data using medians and interquartile ranges. Predictors of seroprotection were analyzed using a logistic regression model reporting odds ratios (ORs), 95% confidence limits, and <em>P</em> values set at 0.05. We conducted only a univariate analysis owing to the limited sample size of our study. We corrected for missing categorical data using the case-deletion correction method. Continuous missing data were assessed to determine the level of missingness and excluded if more than 50% of the data were missing with no data excluded. All <em>P</em> values were statistically significant if the <em>P</em> value of the test was 0.05 or less. All analyses were conducted using STATA version 18 (StataCorp. 2023. Stata Statistical Software: Release 18.: StataCorp LLC.).</p></section></section><section id="sec8"><h2 class="pmc_sec_title">RESULTS</h2>
<p>Eighty-five patients met the inclusion criteria with a mean age of 50 years. Forty-four (52%) were males, and the majority were Caucasian (92%; Table <a href="#T1" class="usa-link">1</a>). About a quarter of the cohort, 22 (26%) were previous HepB primary nonresponders. At the time of vaccination, the majority 65 (76%) were on advanced therapy; 33 (39%) were on TNF monotherapy or combination therapy, 21 (25%) were on vedolizumab monotherapy, and 10 (12%) patients were on ustekinumab monotherapy or combination therapy.</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">TABLE 1.</h3>
<div class="caption p"><p>Baseline Demographics of Patients With IBD Who Received a 2-Dose Heplisav-B Vaccine</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<thead><tr>
<th align="left" colspan="1" axis="1" rowspan="1">Baseline demographics</th>
<th align="center" colspan="1" axis="1" rowspan="1">At Heplisav-B dose #2; n = 85</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age median (interquartile range)</td>
<td align="center" colspan="1" rowspan="1">52 (42-62)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">44 (52)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Race/ethnicity</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Caucasian</td>
<td align="center" colspan="1" rowspan="1">78 (92)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> African American</td>
<td align="center" colspan="1" rowspan="1">3 (4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Asian</td>
<td align="center" colspan="1" rowspan="1">3 (4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Other</td>
<td align="center" colspan="1" rowspan="1">1 (1)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">IBD diagnosis</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CD</td>
<td align="center" colspan="1" rowspan="1">54 (64)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> UC</td>
<td align="center" colspan="1" rowspan="1">31 (36)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary HepB vaccine nonresponders</td>
<td align="center" colspan="1" rowspan="1">22 (26)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No therapy or aminosalicylate monotherapy</td>
<td align="center" colspan="1" rowspan="1">19 (22)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vedolizumab monotherapy</td>
<td align="center" colspan="1" rowspan="1">21 (25)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Thiopurine monotherapy</td>
<td align="center" colspan="1" rowspan="1">1 (1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-TNF monotherapy</td>
<td align="center" colspan="1" rowspan="1">19 (22)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-TNF combination therapy</td>
<td align="center" colspan="1" rowspan="1">14 (16)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ustekinumab monotherapy or combo therapy</td>
<td align="center" colspan="1" rowspan="1">10 (12)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tofacitinib therapy</td>
<td align="center" colspan="1" rowspan="1">1 (1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">On corticosteroid therapy</td>
<td align="center" colspan="1" rowspan="1">14 (16)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Systemic immunosuppression<a href="#T1fn1" class="usa-link"><sup>*</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">49 (58)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn1"><p>Values are median (interquartile range) or n (%).</p></div>
<div class="fn" id="T1fn1">
<sup>*</sup><p class="display-inline">Patients on TNF monotherapy, TNF combination therapy, ustekinumab monotherapy or combination therapy, tofacitinib therapy, or corticosteroids.</p>
</div>
<div class="fn" id="fn3"><p>CD indicates Crohn's disease; HepB, hepatitis B; IBD, inflammatory bowel disease; TNF, tumor necrosis factor; UC, ulcerative colitis.</p></div>
<div class="fn" id="fn4"><p>Bold values are statistical significance of <em>p</em> value.</p></div>
</div></section><p>Most of our cohort (72%) achieved seroprotection after vaccination with the HepB-CpG series with a median anti-HB level of 48.7 IU/mL (Table <a href="#T2" class="usa-link">2</a>). Twenty-eight patients (33%) had anti-HB levels ≥100 IU/mL. Seven (8%) patients received a third dose of the HepB-CpG vaccine after not responding to the original 2-dose series, and 2 patients responded after the third dose.</p>
<section class="tw xbox font-sm" id="T2"><h3 class="obj_head">TABLE 2.</h3>
<div class="caption p"><p>Comparison Between Responders<a href="#T2fn2" class="usa-link"><sup>†</sup></a> and Nonresponders to 2-dose Heplisav-B Vaccine<a href="#T2fn3" class="usa-link"><sup>‡</sup></a>
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<thead><tr>
<th align="left" colspan="1" axis="1" rowspan="1">Variables</th>
<th align="center" colspan="1" axis="1" rowspan="1">Nonresponder; N=24 (28.2%)</th>
<th align="center" colspan="1" axis="1" rowspan="1">Responder; N=61 (71.8%)</th>
<th align="center" colspan="1" axis="1" rowspan="1">Total; N=85 (100.0%)</th>
<th align="center" colspan="1" axis="1" rowspan="1">
<em>P</em>
</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, mean (SD)</td>
<td align="center" colspan="1" rowspan="1">53.3 (13.7)</td>
<td align="center" colspan="1" rowspan="1">48.2 (14.6)</td>
<td align="center" colspan="1" rowspan="1">49.7 (14.5)</td>
<td align="center" colspan="1" rowspan="1">0.150</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HepB surface antibody, median (IQR)</td>
<td align="center" colspan="1" rowspan="1">8.0 (0.0)</td>
<td align="center" colspan="1" rowspan="1">316.9 (920.8)</td>
<td align="center" colspan="1" rowspan="1">48.7 (564.8)</td>
<td align="center" colspan="1" rowspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Age &gt;40 y; n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="center" colspan="1" rowspan="1">22 (91.7)</td>
<td align="center" colspan="1" rowspan="1">45 (73.8)</td>
<td align="center" colspan="1" rowspan="1">67 (78.8)</td>
<td align="center" colspan="1" rowspan="1">0.069</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="center" colspan="1" rowspan="1">2 (8.3)</td>
<td align="center" colspan="1" rowspan="1">16 (26.2)</td>
<td align="center" colspan="1" rowspan="1">18 (21.2)</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age &gt;60 y; n (%)</td>
<td align="center" colspan="1" rowspan="1">9 (37.5)</td>
<td align="center" colspan="1" rowspan="1">16 (26.2)</td>
<td align="center" colspan="1" rowspan="1">25 (29.4)</td>
<td align="center" colspan="1" rowspan="1">0.305</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Sex; n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="center" colspan="1" rowspan="1">9 (37.5)</td>
<td align="center" colspan="1" rowspan="1">32 (52.5)</td>
<td align="center" colspan="1" rowspan="1">41 (48.2)</td>
<td align="center" colspan="1" rowspan="1">0.214</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="center" colspan="1" rowspan="1">15 (62.5)</td>
<td align="center" colspan="1" rowspan="1">29 (47.5)</td>
<td align="center" colspan="1" rowspan="1">44 (51.8)</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Race; n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Caucasian</td>
<td align="center" colspan="1" rowspan="1">23 (95.8)</td>
<td align="center" colspan="1" rowspan="1">55 (90.2)</td>
<td align="center" colspan="1" rowspan="1">78 (91.8)</td>
<td align="center" colspan="1" rowspan="1">0.643</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> African American</td>
<td align="center" colspan="1" rowspan="1">1 (4.2)</td>
<td align="center" colspan="1" rowspan="1">2 (3.3)</td>
<td align="center" colspan="1" rowspan="1">3 (3.5)</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Asian</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">3 (4.9)</td>
<td align="center" colspan="1" rowspan="1">3 (3.5)</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Other</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">1 (1.6)</td>
<td align="center" colspan="1" rowspan="1">1 (1.2)</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">IBD diagnosis; n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CD</td>
<td align="center" colspan="1" rowspan="1">18 (75.0)</td>
<td align="center" colspan="1" rowspan="1">36 (59.0)</td>
<td align="center" colspan="1" rowspan="1">54 (63.5)</td>
<td align="center" colspan="1" rowspan="1">0.168</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> UC</td>
<td align="center" colspan="1" rowspan="1">6 (25.0)</td>
<td align="center" colspan="1" rowspan="1">25 (41.0)</td>
<td align="center" colspan="1" rowspan="1">31 (36.5)</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary HepB vaccine nonresponders; n (%)<a href="#T2fn4" class="usa-link"><sup>§</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">11 (45.8)</td>
<td align="center" colspan="1" rowspan="1">11 (18.0)</td>
<td align="center" colspan="1" rowspan="1">22 (25.9)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.008</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Received a third dose; n (%)<a href="#T2fn5" class="usa-link"><sup>‖</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">5 (20.8)</td>
<td align="center" colspan="1" rowspan="1">2 (3.3)</td>
<td align="center" colspan="1" rowspan="1">7 (8.2)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.008</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Thiopurine monotherapy; n (%)</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">1 (1.6)</td>
<td align="center" colspan="1" rowspan="1">1 (1.2)</td>
<td align="center" colspan="1" rowspan="1">0.528</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vedolizumab monotherapy; n (%)</td>
<td align="center" colspan="1" rowspan="1">4 (16.7)</td>
<td align="center" colspan="1" rowspan="1">17 (27.9)</td>
<td align="center" colspan="1" rowspan="1">21 (24.7)</td>
<td align="center" colspan="1" rowspan="1">0.281</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-TNF monotherapy; n (%)</td>
<td align="center" colspan="1" rowspan="1">6 (25.0)</td>
<td align="center" colspan="1" rowspan="1">13 (21.3)</td>
<td align="center" colspan="1" rowspan="1">19 (22.4)</td>
<td align="center" colspan="1" rowspan="1">0.713</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-TNF combination therapy; n (%)</td>
<td align="center" colspan="1" rowspan="1">6 (25.0)</td>
<td align="center" colspan="1" rowspan="1">8 (13.1)</td>
<td align="center" colspan="1" rowspan="1">14 (16.5)</td>
<td align="center" colspan="1" rowspan="1">0.184</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ustekinumab therapy; n (%)</td>
<td align="center" colspan="1" rowspan="1">4 (16.7)</td>
<td align="center" colspan="1" rowspan="1">6 (9.8)</td>
<td align="center" colspan="1" rowspan="1">10 (11.8)</td>
<td align="center" colspan="1" rowspan="1">0.379</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tofacitinib therapy; n (%)</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">1 (1.6)</td>
<td align="center" colspan="1" rowspan="1">1 (1.2)</td>
<td align="center" colspan="1" rowspan="1">0.528</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Systemic immunosuppression; n (%)<a href="#T2fn1" class="usa-link"><sup>*</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">18 (75.0)</td>
<td align="center" colspan="1" rowspan="1">31 (50.8)</td>
<td align="center" colspan="1" rowspan="1">49 (57.6)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.042</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T2fn1">
<sup>
<sup>*</sup>
</sup><p class="display-inline">Patients on thiopurine monotherapy, TNF monotherapy, TNF combination therapy, ustekinumab monotherapy or combination therapy, tofacitinib therapy, or corticosteroids.</p>
</div>
<div class="fn" id="T2fn2">
<sup>
<sup>†</sup>
</sup><p class="display-inline">Patients who had anti-HBs &gt;10 after 2-dose series of HepB-CpG.</p>
</div>
<div class="fn" id="T2fn3">
<sup>
<sup>‡</sup>
</sup><p class="display-inline">Patients who had anti-HBs &lt;10 after 2-dose series of HepB-CpG.</p>
</div>
<div class="fn" id="T2fn4">
<sup>
<sup>§</sup>
</sup><p class="display-inline">Patients who received a HepB vaccine series and did not achieve seroprotection and did not respond to a HepB challenge dose before receiving HepB-CpG.</p>
</div>
<div class="fn" id="T2fn5">
<sup>
<sup>‖</sup>
</sup><p class="display-inline">Seven of the 24 nonresponders received a third dose after having anti-HBs &lt;10 after 2-dose series of HepB-CpG.</p>
</div>
<div class="fn" id="fn10"><p>CD indicates Crohn's disease; HepB, hepatitis B; IBD, inflammatory bowel disease; IQR, interquartile range; TNF, tumor necrosis factor; UC, ulcerative colitis.</p></div>
</div></section><section id="sec9"><h3 class="pmc_sec_title">Predictors of Responding and Achieving Seroprotection</h3>
<p>Those on systemic immunosuppressive therapy were less likely to respond to HepB-CpG than those on nonsystemic immunosuppressive therapy (n = 49 vs N = 36, <em>P</em> = 0.042). Patients who were previous primary HepB nonresponders were less likely to respond to HepB-CpG when compared with those who were HepB naïve (n = 22 vs N = 63, <em>P</em> = 0.008). Those 40 years of age or older were less likely to respond to HepB-CpG B when compared with those younger than 40 years, although this difference was not statistically significant. There were no significant differences in sex, IBD diagnosis, and use of thiopurine monotherapy, vedolizumab monotherapy, anti-TNF monotherapy, anti-TNF combination therapy, ustekinumab therapy, or tofacitinib therapy between the two groups.</p></section><section id="sec10"><h3 class="pmc_sec_title">Univariate Analysis</h3>
<p>In a univariate analysis evaluating seroprotection after the second dose, systemic immunosuppressive therapy (OR: 0.34, <em>P</em> = 0.047) and a history of nonresponse to a previous HepB series (OR: 0.26, <em>P</em> = 0.011) were predictive of a poor response to HepB-CpG (Table <a href="#T3" class="usa-link">3</a>). Older age (≥40 y; OR: 0.26, <em>P</em> = 0.086) was also predictive of nonresponse to HepB-CpG, although this difference was not statistically significant. No other variables were associated with increased or decreased response rates to HepB-CpG in the univariate model.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Univariate Analysis Predictors of Not Achieving Seroprotection to HepB</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<col align="left" width="1*" span="1">
<thead><tr>
<th align="left" colspan="1" axis="1" rowspan="1">Variables</th>
<th align="center" colspan="1" axis="1" rowspan="1">OR</th>
<th align="center" colspan="1" axis="1" rowspan="1">95% CI</th>
<th align="center" colspan="1" axis="1" rowspan="1">
<em>P</em>
</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age</td>
<td align="center" colspan="1" rowspan="1">0.97</td>
<td align="center" colspan="1" rowspan="1">0.94-1.01</td>
<td align="center" colspan="1" rowspan="1">0.152</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age &gt;40 y</td>
<td align="center" colspan="1" rowspan="1">0.26</td>
<td align="center" colspan="1" rowspan="1">0.05-1.21</td>
<td align="center" colspan="1" rowspan="1">0.086</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age &gt;60 y</td>
<td align="center" colspan="1" rowspan="1">0.59</td>
<td align="center" colspan="1" rowspan="1">0.22-1.62</td>
<td align="center" colspan="1" rowspan="1">0.307</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sex (M)</td>
<td align="center" colspan="1" rowspan="1">0.54</td>
<td align="center" colspan="1" rowspan="1">0.21-1.43</td>
<td align="center" colspan="1" rowspan="1">0.217</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Race (non-white)</td>
<td align="center" colspan="1" rowspan="1">2.51</td>
<td align="center" colspan="1" rowspan="1">0.29-22.0</td>
<td align="center" colspan="1" rowspan="1">0.407</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1">IBD diagnosis</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CD</td>
<td align="center" colspan="1" rowspan="1">Reference</td>
<td align="center" colspan="1" rowspan="1">Reference</td>
<td align="center" colspan="1" rowspan="1">Reference</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> UC</td>
<td align="center" colspan="1" rowspan="1">2.08</td>
<td align="center" colspan="1" rowspan="1">0.73-5.98</td>
<td align="center" colspan="1" rowspan="1">0.173</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary HepB vaccine nonresponders<a href="#T3fn2" class="usa-link"><sup>†</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">0.26</td>
<td align="center" colspan="1" rowspan="1">0.09-0.73</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.011</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vedolizumab monotherapy</td>
<td align="center" colspan="1" rowspan="1">1.93</td>
<td align="center" colspan="1" rowspan="1">0.58-6.48</td>
<td align="center" colspan="1" rowspan="1">0.286</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-TNF therapy</td>
<td align="center" colspan="1" rowspan="1">0.53</td>
<td align="center" colspan="1" rowspan="1">0.20-1.37</td>
<td align="center" colspan="1" rowspan="1">0.188</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ustekinumab therapy</td>
<td align="center" colspan="1" rowspan="1">0.54</td>
<td align="center" colspan="1" rowspan="1">0.14-2.14</td>
<td align="center" colspan="1" rowspan="1">0.384</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Systemic immunosuppression<a href="#T3fn1" class="usa-link"><sup>*</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">0.34</td>
<td align="center" colspan="1" rowspan="1">0.12-0.99</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.047</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T3fn1">
<sup>
<sup>*</sup>
</sup><p class="display-inline">Patients on thiopurine monotherapy, TNF monotherapy, TNF combination therapy, ustekinumab monotherapy or combination therapy, tofacitinib therapy, or corticosteroids.</p>
</div>
<div class="fn" id="T3fn2">
<sup>
<sup>†</sup>
</sup><p class="display-inline">Patients who had anti-HBs &gt;10 after 2-dose series of HepB-CpG.</p>
</div>
<div class="fn" id="fn13"><p>CD indicates Crohn's disease; HepB, hepatitis B; IBD, inflammatory bowel disease; OR, odds ratio; TNF, tumor necrosis factor; UC, ulcerative colitis.</p></div>
</div></section></section></section><section id="sec11"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>Patients with IBD are at high risk for the reactivation of HBV infection due to immunosuppressive therapies.<sup><a href="#R27" class="usa-link" aria-describedby="R27">27</a></sup> Response rates to the 3-dose recombinant HepB series are suboptimal in this patient population.<sup><a href="#R28" class="usa-link" aria-describedby="R28">28</a></sup> To the best of our knowledge, this is the first prospective observational study to evaluate seroprotection of the 2-dose HepB-CpG series in patients with IBD with seroprotection rates of 72%. This is greater than the response rate ranging from 34% to 59% in studies investigating the widely used 3-dose recombinant HepB series in populations with similar immunosuppression therapy profiles.<sup><a href="#R29" class="usa-link" aria-describedby="R29">29</a>,<a href="#R30" class="usa-link" aria-describedby="R30">30</a></sup> Further dividing patients into subgroups allowed us to examine predictors of seroprotection to HepB-CpG.</p>
<p>Immunosuppressive therapies including corticosteroids, biologics, and immunomodulators are associated with poor vaccine response.<sup><a href="#R31" class="usa-link" aria-describedby="R31">31</a></sup> We saw a significantly lower seroprotection rate to HepB-CpG in patients with IBD on systemic immunosuppressive therapy compared with those on nonsystemic immunosuppressive therapy. This is consistent with previous literature examining HepB response in patients with IBD on immunosuppressive therapy. Altunöz et al<sup><a href="#R32" class="usa-link" aria-describedby="R32">32</a></sup> reported a significantly lower response rate to HepB in patients with IBD on systemic immunosuppressive therapy (corticosteroids, azathioprine, and anti-TNF) compared with patients not on systemic immunosuppressive therapy. Concerning the influence of anti-TNF agents on HepB response in patients with IBD, Gisbert et al<sup><a href="#R30" class="usa-link" aria-describedby="R30">30</a></sup> found a decreased response rate among patients on anti-TNF therapy (46%) compared with those who were not (62%). Although we saw a lower rate of seroprotection to HepB-CpG in patients on anti-TNF therapy compared with those who were not, this difference was not statistically significant. The literature on the effect of vedolizumab and ustekinumab therapy on HepB response rate in patients with IBD is limited. While we observed a higher rate of seroprotection to HepB-CpG in patients on vedolizumab therapy compared with those who were not, this difference was not statistically significant. In addition, while we found a lower rate of seroprotection to HepB-CpG in patients on ustekinumab therapy compared with those who were not, this response was also not statistically significant in univariate analysis.</p>
<p>Few data are available on the effectiveness of revaccination in primary HepB nonresponders to the 3-dose recombinant HepB series in patients with IBD. In their retrospective cohort study, Pratt Jr. et al<sup><a href="#R33" class="usa-link" aria-describedby="R33">33</a></sup> demonstrated that after initial HepB vaccine nonresponse, patients with IBD are more likely to develop seroprotection to HBV after 3 additional vaccine doses, rather than 1 or 2 alone. While this demonstrates the importance of an additional 3-dose revaccination strategy with widely used HepB schedules, the effectiveness of revaccination with HepB-CpG after primary HepB failure in patients with IBD has not been studied. In our study, out of the 7 patients who received a third dose of HepB-CpG after not responding to the original 2-dose series, 2 (29%) achieved seroprotection. In addition, patients who failed a 2-dose series of HepB-CpG and received a third dose were significantly less likely to achieve seroprotection when compared with those who responded to a 2-dose series.</p>
<p>Increasing age contributes to decreased vaccine response due to changes in immune function.<sup><a href="#R34" class="usa-link" aria-describedby="R34">34</a></sup> Age-associated alterations in lymph nodes, reduced production of B lymphocytes, and impaired activation of T lymphocytes contribute to a decrease in vaccine effectiveness.<sup><a href="#R35" class="usa-link" aria-describedby="R35">35</a></sup> As a result, older patients have a significantly increased risk of nonresponse to HepB.<sup><a href="#R36" class="usa-link" aria-describedby="R36">36</a></sup> We found a significantly lower rate of seroprotection to HepB-CpG in patients with IBD older than 40 years of age when compared with those younger than 40 years of age, but this difference was not statistically significant in univariate analysis. The absence of statistical significance concerning age in our study may be due to its limited sample size. Based on these observations, it is essential to test for immunogenicity to HBV at the time of IBD diagnosis and minimize the time to HepB vaccination.</p>
<p>Patients who have an anti-HB level &lt;10 after a primary HepB series are considered primary nonresponders. HepB-CpG has demonstrated a high rate of seroprotection in primary HepB nonresponders, including those with chronic medical conditions such as human immunodeficiency virus.<sup><a href="#R37" class="usa-link" aria-describedby="R37">37</a>,<a href="#R38" class="usa-link" aria-describedby="R38">38</a></sup> The data on HepB-CpG efficacy in patients with IBD who are primary HepB nonresponders are limited. Twenty-two participants in our study failed a previous HepB series, and 11 (50%) responded to HepB-CpG. In addition, we observed a significantly lower rate of seroprotection to HepB-CpG in patients with IBD who were primary HepB nonresponders when compared with those who were HepB naïve. This could be attributed to differences in certain characteristics between the two groups. Predictors of HepB nonresponse have been shown to include increasing age, male gender, tobacco use, obesity, immunosuppressive therapy, chronic disease, and genetic predisposition.<sup><a href="#R39" class="usa-link" aria-describedby="R39">39</a>,<a href="#R40" class="usa-link" aria-describedby="R40">40</a></sup> A recent study investigating the utility of a third HepB-CpG dose in patients with IBD who did not seroconvert after a 2-dose series (28.1%) demonstrated that patients who had diabetes, chronic kidney disease, or were male were more likely to not respond to a primary 2-dose series.<sup><a href="#R41" class="usa-link" aria-describedby="R41">41</a></sup> The majority of patients (56.7%) did not respond to the initial 2-dose series of HepB-CpG seroconverted after a third dose.</p>
<p>There are many advantages to HepB-CpG when compared with the widely available HepB series other than its increased immune response. HepB-CpG is more cost-effective for patients with IBD than historically used HepB schedules with a similar safety profile in the general population.<sup><a href="#R42" class="usa-link" aria-describedby="R42">42</a></sup> In addition, when compared with the traditional 3-dose recombinant HepB series with a schedule of 3 doses over 6 months, HepB-CpG has fewer doses in a shorter time (2 doses over 1 mo), which may increase patient compliance and offers faster protection against HBV infection. In their nested cohort study, Bruxvoort et al<sup><a href="#R43" class="usa-link" aria-describedby="R43">43</a></sup> observed a significantly higher rate of HepB vaccine series completion with HepB-CpG when compared with the 3-dose series. Oster et al<sup><a href="#R44" class="usa-link" aria-describedby="R44">44</a></sup> demonstrated that the use of a 2-dose instead of a 3-dose HepB series would raise the potential adults seroprotected at one year by 275,000 per one million persons. Lastly, HepB-CpG is interchangeable, and patients who begin a 3-dose vaccination series can complete the series with 2 additional doses of HepB-CpG. Given the higher seroprotection rate and easier immunization schedule of HepB-CpG, this may be the preferred option for patients with IBD in the United States, UK, and other countries where it is approved for use.</p>
<p>Our study has many notable strengths. This is the first prospective observational study to assess the immunogenicity of HepB-CpG in patients with IBD. We examined patients with IBD on stable and diverse treatment regimens at a gastroenterology tertiary care center reflecting current practice recommendations. We provided a challenge dose with HepB-CpG to individuals with a previous HepB immunization history who were not seroprotected to determine whether they were true primary nonresponders to HepB. Due to the strict inclusion and exclusion criteria of our study, potential biases and confounding variables were limited. We carried out multiple secondary analyses to evaluate the immune response of HepB-CpG in several subgroups of our IBD participants. While many vaccine coverage studies rely on subject survey responses and incomplete electronic medical records, the vaccination history of our subjects was verified using a validated statewide immunization registry.</p>
<p>Our study was not without limitations. Its prospective and observational nature makes it more prone to bias and confounding due to the lack of randomization of exposure. The limited sample size of our study could have resulted in some analyses not reaching statistical significance due to a decrease in statistical power. Some sample sizes were small, particularly those in the thiopurine monotherapy and tofacitinib cohort, making it difficult to draw associations for specific subgroups. As a single-center study, our participants may not necessarily represent the qualities of the general IBD patient population. We observed a level of homogeneity in our study, with participants predominantly identifying as white, which precludes extrapolating the results to a population with greater racial diversity. Noting these limitations, the relationships we have reported will support the future design of larger and controlled investigations.</p></section><section id="sec12"><h2 class="pmc_sec_title">CONCLUSION</h2>
<p>HepB-CpG is a 2-dose adjuvanted vaccine that achieved higher rates of seroprotection than the commonly used 3-dose recombinant HepB series in patients with IBD. Given that patients with IBD are recommended to get immunized against HBV, HepB-CpG may be the preferred option due to its superior seroprotection rate and easier immunization schedule. Future controlled studies are needed to better elucidate predictors of immunogenicity to HepB-CpG in patients with IBD on non-TNF biologics and other novel therapies.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn14"><p>Y.H.: acquisition of data, analysis and interpretation of data, drafted the manuscript, and critically revised the manuscript. S.K.L.: acquisition of data. F.H.: analysis of data and critical revision of the manuscript. M.S.H.: analysis and interpretation of data and critical revision of the manuscript. F.A.F.: critical revision of the manuscript. F.C.: study concept and design, analysis and interpretation of data, drafted the manuscript, and critically revised the manuscript.</p></div>
<div class="fn p" id="fn15"><p>The data underlying this article will be shared on reasonable request to the corresponding author.</p></div>
<div class="fn p" id="fn16"><p>F.C. has received research support from GSK, Takeda Pharmaceuticals, Janssen and Novavax. He has been a consultant for Takeda, Arena Pharmaceuticals, GSK, and Celgene. F.A.F. is a consultant for AbbVie, Avalo Therapeutics, Bausch, BMS, Braintree Labs, Fresenius Kabi, GI Reviewers, GSK, Iterative Health, Janssen, Pfizer, Sandoz Immunology, Sebela and Viatris. He sits on a DSMB for Lilly Pharmaceuticals. M.S.H. is a consultant for GSK Vaccines and Seqirus and has received research support from Takeda Pharmaceuticals and Dynavax. The remaining authors declare that they have nothing to disclose.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Yash Hegde, Email: yhegde@uwhealth.org.</p>
<p>Sarah K. Lazarus, Email: Sarah.lazarus@hcmed.org.</p>
<p>Francis A. Farraye, Email: farraye.francis@mayo.edu.</p>
<p>Fauzia Hollnagel, Email: fhollnagel@medicine.wisc.edu.</p>
<p>Mary S. Hayney, Email: mary.hayney@wisc.edu.</p>
<p>Freddy Caldera, Email: fcaldera@medicine.wisc.edu.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.
</cite> [<a href="https://doi.org/10.14309/ajg.0000000000000152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30840605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=ACG%20clinical%20guideline:%20ulcerative%20colitis%20in%20adults&amp;author=DT%20Rubin&amp;author=AN%20Ananthakrishnan&amp;author=CA%20Siegel&amp;volume=114&amp;publication_year=2019&amp;pages=384-413&amp;pmid=30840605&amp;doi=10.14309/ajg.0000000000000152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Ho EY, Singh S, Terdiman JP. Providing the best care for patients with Crohn’s disease: an examination of the new AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease. Gastroenterology. 2021;160:2557–2562.
</cite> [<a href="https://doi.org/10.1053/j.gastro.2021.04.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34051986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Providing%20the%20best%20care%20for%20patients%20with%20Crohn%E2%80%99s%20disease:%20an%20examination%20of%20the%20new%20AGA%20clinical%20practice%20guidelines%20on%20the%20medical%20management%20of%20moderate%20to%20severe%20luminal%20and%20perianal%20fistulizing%20Crohn%E2%80%99s%20disease&amp;author=EY%20Ho&amp;author=S%20Singh&amp;author=JP%20Terdiman&amp;volume=160&amp;publication_year=2021&amp;pages=2557-2562&amp;pmid=34051986&amp;doi=10.1053/j.gastro.2021.04.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Loomba R, Liang TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology. 2017;152:1297–1309.
</cite> [<a href="https://doi.org/10.1053/j.gastro.2017.02.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5501983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28219691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Hepatitis%20B%20reactivation%20associated%20with%20immune%20suppressive%20and%20biological%20modifier%20therapies:%20current%20concepts,%20management%20strategies,%20and%20future%20directions&amp;author=R%20Loomba&amp;author=TJ%20Liang&amp;volume=152&amp;publication_year=2017&amp;pages=1297-1309&amp;pmid=28219691&amp;doi=10.1053/j.gastro.2017.02.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Loras C Gisbert JP Mínguez M et al. REPENTINA study , GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group . Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59:1340–1346.
</cite> [<a href="https://doi.org/10.1136/gut.2010.208413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20577000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Liver%20dysfunction%20related%20to%20hepatitis%20B%20and%20C%20in%20patients%20with%20inflammatory%20bowel%20disease%20treated%20with%20immunosuppressive%20therapy&amp;author=C%20Loras&amp;author=JP%20Gisbert&amp;author=M%20M%C3%ADnguez&amp;volume=59&amp;publication_year=2010&amp;pages=1340-1346&amp;pmid=20577000&amp;doi=10.1136/gut.2010.208413&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Park SH, Yang SK, Lim YS, et al. Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases. Inflamm Bowel Dis. 2012;18:2004–2010.
</cite> [<a href="https://doi.org/10.1002/ibd.22905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22337144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm%20Bowel%20Dis&amp;title=Clinical%20courses%20of%20chronic%20hepatitis%20B%20virus%20infection%20and%20inflammatory%20bowel%20disease%20in%20patients%20with%20both%20diseases&amp;author=SH%20Park&amp;author=SK%20Yang&amp;author=YS%20Lim&amp;volume=18&amp;publication_year=2012&amp;pages=2004-2010&amp;pmid=22337144&amp;doi=10.1002/ibd.22905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Belle A, Baumann C, Bigard MA, et al. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases. Eur J Gastroenterol Hepatol. 2015;27:877–881.
</cite> [<a href="https://doi.org/10.1097/MEG.0000000000000370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26121376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Gastroenterol%20Hepatol&amp;title=Impact%20of%20immunosuppressive%20therapy%20on%20hepatitis%20B%20vaccination%20in%20inflammatory%20bowel%20diseases&amp;author=A%20Belle&amp;author=C%20Baumann&amp;author=MA%20Bigard&amp;volume=27&amp;publication_year=2015&amp;pages=877-881&amp;pmid=26121376&amp;doi=10.1097/MEG.0000000000000370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Farraye FA, Melmed GY, Lichtenstein GR, et al. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241–258. Erratum in: Am J Gastroenterol. 2017;112(7):1208.
</cite> [<a href="https://doi.org/10.1038/ajg.2016.537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28071656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=ACG%20clinical%20guideline:%20preventive%20care%20in%20inflammatory%20bowel%20disease&amp;author=FA%20Farraye&amp;author=GY%20Melmed&amp;author=GR%20Lichtenstein&amp;volume=112&amp;publication_year=2017&amp;pages=241-258&amp;pmid=28071656&amp;doi=10.1038/ajg.2016.537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Jones JL, Tse F, Carroll MW, et al. Canadian Association of Gastroenterology clinical practice guideline for immunizations in patients with inflammatory bowel disease (IBD)-part 2: inactivated vaccines. J Can Assoc Gastroenterol. 2021;4:e72–e91.
</cite> [<a href="https://doi.org/10.1093/jcag/gwab016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8407486/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34476339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Can%20Assoc%20Gastroenterol&amp;title=Canadian%20Association%20of%20Gastroenterology%20clinical%20practice%20guideline%20for%20immunizations%20in%20patients%20with%20inflammatory%20bowel%20disease%20(IBD)-part%202:%20inactivated%20vaccines&amp;author=JL%20Jones&amp;author=F%20Tse&amp;author=MW%20Carroll&amp;volume=4&amp;publication_year=2021&amp;pages=e72-e91&amp;pmid=34476339&amp;doi=10.1093/jcag/gwab016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Kucharzik T, Ellul P, Greuter T, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021;15:879–913.Erratum in: J Crohns Colitis. 2022;16.
</cite> [<a href="https://doi.org/10.1093/ecco-jcc/jjab052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33730753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Crohns%20Colitis&amp;title=ECCO%20guidelines%20on%20the%20prevention,%20diagnosis,%20and%20management%20of%20infections%20in%20inflammatory%20bowel%20disease&amp;author=T%20Kucharzik&amp;author=P%20Ellul&amp;author=T%20Greuter&amp;volume=15&amp;publication_year=2021&amp;pages=879-913&amp;pmid=33730753&amp;doi=10.1093/ecco-jcc/jjab052&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Kochhar GS, Mohan BP, Khan SR, et al. Hepatitis-B vaccine response in inflammatory bowel disease patients: a systematic review and meta-analysis. Inflamm Bowel Dis. 2021;27:1610–1619.
</cite> [<a href="https://doi.org/10.1093/ibd/izaa353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33393585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm%20Bowel%20Dis&amp;title=Hepatitis-B%20vaccine%20response%20in%20inflammatory%20bowel%20disease%20patients:%20a%20systematic%20review%20and%20meta-analysis&amp;author=GS%20Kochhar&amp;author=BP%20Mohan&amp;author=SR%20Khan&amp;volume=27&amp;publication_year=2021&amp;pages=1610-1619&amp;pmid=33393585&amp;doi=10.1093/ibd/izaa353&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Loras C Gisbert JP Saro MC et al. REPENTINA study, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa) . Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3). J Crohns Colitis. 2014;8:1529–1538.
</cite> [<a href="https://doi.org/10.1016/j.crohns.2014.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25052345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Crohns%20Colitis&amp;title=Impact%20of%20surveillance%20of%20hepatitis%20b%20and%20hepatitis%20c%20in%20patients%20with%20inflammatory%20bowel%20disease%20under%20anti-TNF%20therapies:%20multicenter%20prospective%20observational%20study%20(REPENTINA%203)&amp;author=C%20Loras&amp;author=JP%20Gisbert&amp;author=MC%20Saro&amp;volume=8&amp;publication_year=2014&amp;pages=1529-1538&amp;pmid=25052345&amp;doi=10.1016/j.crohns.2014.06.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Hansen B, Belfast M, Soung G, et al. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine. 2009;27:888–892.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2008.11.078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19071182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Effect%20of%20the%20strength%20of%20adsorption%20of%20hepatitis%20B%20surface%20antigen%20to%20aluminum%20hydroxide%20adjuvant%20on%20the%20immune%20response&amp;author=B%20Hansen&amp;author=M%20Belfast&amp;author=G%20Soung&amp;volume=27&amp;publication_year=2009&amp;pages=888-892&amp;pmid=19071182&amp;doi=10.1016/j.vaccine.2008.11.078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Van Den Ende C, Marano C, Van Ahee A, et al. The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Rev Vaccines. 2017;16:811–832.
</cite> [<a href="https://doi.org/10.1080/14760584.2017.1338568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28573913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev%20Vaccines&amp;title=The%20immunogenicity%20and%20safety%20of%20GSK%E2%80%99s%20recombinant%20hepatitis%20B%20vaccine%20in%20adults:%20a%20systematic%20review%20of%2030%20years%20of%20experience&amp;author=C%20Van%20Den%20Ende&amp;author=C%20Marano&amp;author=A%20Van%20Ahee&amp;volume=16&amp;publication_year=2017&amp;pages=811-832&amp;pmid=28573913&amp;doi=10.1080/14760584.2017.1338568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Keating GM, Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs. 2003;63:1021–1051.
</cite> [<a href="https://doi.org/10.2165/00003495-200363100-00006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12699402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Recombinant%20hepatitis%20B%20vaccine%20(Engerix-B):%20a%20review%20of%20its%20immunogenicity%20and%20protective%20efficacy%20against%20hepatitis%20B&amp;author=GM%20Keating&amp;author=S%20Noble&amp;volume=63&amp;publication_year=2003&amp;pages=1021-1051&amp;pmid=12699402&amp;doi=10.2165/00003495-200363100-00006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Van Der Meeren O, Crasta P, Cheuvart B, et al. Characterization of an age-response relationship to GSK’s recombinant hepatitis B vaccine in healthy adults: an integrated analysis. Hum Vaccin Immunother. 2015;11:1726–1729.
</cite> [<a href="https://doi.org/10.1080/21645515.2015.1039758" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4514334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25996260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Vaccin%20Immunother&amp;title=Characterization%20of%20an%20age-response%20relationship%20to%20GSK%E2%80%99s%20recombinant%20hepatitis%20B%20vaccine%20in%20healthy%20adults:%20an%20integrated%20analysis&amp;author=O%20Van%20Der%20Meeren&amp;author=P%20Crasta&amp;author=B%20Cheuvart&amp;volume=11&amp;publication_year=2015&amp;pages=1726-1729&amp;pmid=25996260&amp;doi=10.1080/21645515.2015.1039758&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Schillie SF, Spradling PR, Murphy TV. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care. 2012;35:2690–2697.
</cite> [<a href="https://doi.org/10.2337/dc12-0312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3507602/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23173138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Immune%20response%20of%20hepatitis%20B%20vaccine%20among%20persons%20with%20diabetes:%20a%20systematic%20review%20of%20the%20literature&amp;author=SF%20Schillie&amp;author=PR%20Spradling&amp;author=TV%20Murphy&amp;volume=35&amp;publication_year=2012&amp;pages=2690-2697&amp;pmid=23173138&amp;doi=10.2337/dc12-0312&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Girndt M, Houser P, Manllo-Karim R, et al. Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease. Vaccine. 2023;41:3224–3232.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2023.04.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37085451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Long-term%20immunogenicity%20and%20safety%20of%20the%20hepatitis%20B%20vaccine%20HepB-CpG%20(HEPLISAV-B)%20compared%20with%20HepB-Eng%20(Engerix-B)%20in%20adults%20with%20chronic%20kidney%20disease&amp;author=M%20Girndt&amp;author=P%20Houser&amp;author=R%20Manllo-Karim&amp;volume=41&amp;publication_year=2023&amp;pages=3224-3232&amp;pmid=37085451&amp;doi=10.1016/j.vaccine.2023.04.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Hyer RN, Janssen RS. Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years. Vaccine. 2019;37:5854–5861.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2019.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31431412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunogenicity%20and%20safety%20of%20a%202-dose%20hepatitis%20B%20vaccine,%20HBsAg/CpG%201018,%20in%20persons%20with%20diabetes%20mellitus%20aged%2060-70%E2%80%AFyears&amp;author=RN%20Hyer&amp;author=RS%20Janssen&amp;volume=37&amp;publication_year=2019&amp;pages=5854-5861&amp;pmid=31431412&amp;doi=10.1016/j.vaccine.2019.08.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Schillie S, Harris A, Link-Gelles R, et al. Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018;67:455–458.
</cite> [<a href="https://doi.org/10.15585/mmwr.mm6715a5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6191098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29672472/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&amp;title=Recommendations%20of%20the%20advisory%20committee%20on%20immunization%20practices%20for%20use%20of%20a%20hepatitis%20B%20vaccine%20with%20a%20novel%20adjuvant&amp;author=S%20Schillie&amp;author=A%20Harris&amp;author=R%20Link-Gelles&amp;volume=67&amp;publication_year=2018&amp;pages=455-458&amp;pmid=29672472&amp;doi=10.15585/mmwr.mm6715a5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Kwon JY, Daoud ND, Hashash JG, et al. Efficacy of hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-b) in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2023;29:254–259.
</cite> [<a href="https://doi.org/10.1093/ibd/izac079" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35468183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm%20Bowel%20Dis&amp;title=Efficacy%20of%20hepatitis%20B%20vaccination%20with%20a%20novel%20immunostimulatory%20sequence%20adjuvant%20(Heplisav-b)%20in%20patients%20with%20inflammatory%20bowel%20disease&amp;author=JY%20Kwon&amp;author=ND%20Daoud&amp;author=JG%20Hashash&amp;volume=29&amp;publication_year=2023&amp;pages=254-259&amp;pmid=35468183&amp;doi=10.1093/ibd/izac079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Ley D, Lazarus S, Forati AM, et al. High rates of seroprotection to hepatitis b after a hepatitis B challenge dose in previously vaccinated patients with inflammatory bowel disease on immunosuppressive therapy. Dig Dis Sci. 2024;69:3051–3060.
</cite> [<a href="https://doi.org/10.1007/s10620-024-08527-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38907090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dig%20Dis%20Sci&amp;title=High%20rates%20of%20seroprotection%20to%20hepatitis%20b%20after%20a%20hepatitis%20B%20challenge%20dose%20in%20previously%20vaccinated%20patients%20with%20inflammatory%20bowel%20disease%20on%20immunosuppressive%20therapy&amp;author=D%20Ley&amp;author=S%20Lazarus&amp;author=AM%20Forati&amp;volume=69&amp;publication_year=2024&amp;pages=3051-3060&amp;pmid=38907090&amp;doi=10.1007/s10620-024-08527-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Caldera F, Hillman L, Saha S, et al. Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF Monotherapy: a randomized clinical trial. Inflamm Bowel Dis. 2020;26:593–602.
</cite> [<a href="https://doi.org/10.1093/ibd/izz164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31504526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm%20Bowel%20Dis&amp;title=Immunogenicity%20of%20high%20dose%20influenza%20vaccine%20for%20patients%20with%20inflammatory%20bowel%20disease%20on%20anti-TNF%20Monotherapy:%20a%20randomized%20clinical%20trial&amp;author=F%20Caldera&amp;author=L%20Hillman&amp;author=S%20Saha&amp;volume=26&amp;publication_year=2020&amp;pages=593-602&amp;pmid=31504526&amp;doi=10.1093/ibd/izz164&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Wyant T, Leach T, Sankoh S, et al. Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results. Gut. 2015;64:77–83.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2014-307127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24763133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Vedolizumab%20affects%20antibody%20responses%20to%20immunisation%20selectively%20in%20the%20gastrointestinal%20tract:%20randomised%20controlled%20trial%20results&amp;author=T%20Wyant&amp;author=T%20Leach&amp;author=S%20Sankoh&amp;volume=64&amp;publication_year=2015&amp;pages=77-83&amp;pmid=24763133&amp;doi=10.1136/gutjnl-2014-307127&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Caldera F, Knutson KL, Saha S, et al. Humoral immunogenicity of mRNA COVID-19 vaccines among patients with inflammatory bowel disease and healthy controls. Am J Gastroenterol. 2022;117:176–179.
</cite> [<a href="https://doi.org/10.14309/ajg.0000000000001570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34797219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Humoral%20immunogenicity%20of%20mRNA%20COVID-19%20vaccines%20among%20patients%20with%20inflammatory%20bowel%20disease%20and%20healthy%20controls&amp;author=F%20Caldera&amp;author=KL%20Knutson&amp;author=S%20Saha&amp;volume=117&amp;publication_year=2022&amp;pages=176-179&amp;pmid=34797219&amp;doi=10.14309/ajg.0000000000001570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Koepke R, Petit AB, Ayele RA, et al. Completeness and accuracy of the Wisconsin immunization registry: an evaluation coinciding with the beginning of meaningful use. J Public Health Manag Pract. 2015;21:273–281.
</cite> [<a href="https://doi.org/10.1097/PHH.0000000000000216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25590511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Public%20Health%20Manag%20Pract&amp;title=Completeness%20and%20accuracy%20of%20the%20Wisconsin%20immunization%20registry:%20an%20evaluation%20coinciding%20with%20the%20beginning%20of%20meaningful%20use&amp;author=R%20Koepke&amp;author=AB%20Petit&amp;author=RA%20Ayele&amp;volume=21&amp;publication_year=2015&amp;pages=273-281&amp;pmid=25590511&amp;doi=10.1097/PHH.0000000000000216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Koepke R, Eickhoff JC, Ayele RA, et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis. 2014;210:942–953.
</cite> [<a href="https://doi.org/10.1093/infdis/jiu322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24903664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Dis&amp;title=Estimating%20the%20effectiveness%20of%20tetanus-diphtheria-acellular%20pertussis%20vaccine%20(Tdap)%20for%20preventing%20pertussis:%20evidence%20of%20rapidly%20waning%20immunity%20and%20difference%20in%20effectiveness%20by%20Tdap%20brand&amp;author=R%20Koepke&amp;author=JC%20Eickhoff&amp;author=RA%20Ayele&amp;volume=210&amp;publication_year=2014&amp;pages=942-953&amp;pmid=24903664&amp;doi=10.1093/infdis/jiu322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Tolentino YF, Fogaca HS, Zaltman C, et al. Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho University Hospital. World J Gastroenterol. 2008;14:3201–3206.
</cite> [<a href="https://doi.org/10.3748/wjg.14.3201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2712853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18506926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Gastroenterol&amp;title=Hepatitis%20B%20virus%20prevalence%20and%20transmission%20risk%20factors%20in%20inflammatory%20bowel%20disease%20patients%20at%20Clementino%20Fraga%20Filho%20University%20Hospital&amp;author=YF%20Tolentino&amp;author=HS%20Fogaca&amp;author=C%20Zaltman&amp;volume=14&amp;publication_year=2008&amp;pages=3201-3206&amp;pmid=18506926&amp;doi=10.3748/wjg.14.3201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Jiang HY, Wang SY, Deng M, et al. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: a systematic review and meta-analysis. Vaccine. 2017;35:2633–2641.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2017.03.080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28404358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immune%20response%20to%20hepatitis%20B%20vaccination%20among%20people%20with%20inflammatory%20bowel%20diseases:%20a%20systematic%20review%20and%20meta-analysis&amp;author=HY%20Jiang&amp;author=SY%20Wang&amp;author=M%20Deng&amp;volume=35&amp;publication_year=2017&amp;pages=2633-2641&amp;pmid=28404358&amp;doi=10.1016/j.vaccine.2017.03.080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Vida Pérez L, Gómez Camacho F, García Sánchez V, et al. Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease. Med Clin (Barc). 2009;132:331–335.
</cite> [<a href="https://doi.org/10.1016/j.medcli.2008.07.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19268981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20Clin%20(Barc)&amp;title=Adequate%20rate%20of%20response%20to%20hepatitis%20B%20virus%20vaccination%20in%20patients%20with%20inflammatory%20bowel%20disease&amp;author=L%20Vida%20P%C3%A9rez&amp;author=F%20G%C3%B3mez%20Camacho&amp;author=V%20Garc%C3%ADa%20S%C3%A1nchez&amp;volume=132&amp;publication_year=2009&amp;pages=331-335&amp;pmid=19268981&amp;doi=10.1016/j.medcli.2008.07.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Gisbert JP, Villagrasa JR, Rodríguez-Nogueiras A, et al. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease. Am J Gastroenterol. 2012;107:1460–1466.
</cite> [<a href="https://doi.org/10.1038/ajg.2012.79" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23034605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Efficacy%20of%20hepatitis%20B%20vaccination%20and%20revaccination%20and%20factors%20impacting%20on%20response%20in%20patients%20with%20inflammatory%20bowel%20disease&amp;author=JP%20Gisbert&amp;author=JR%20Villagrasa&amp;author=A%20Rodr%C3%ADguez-Nogueiras&amp;volume=107&amp;publication_year=2012&amp;pages=1460-1466&amp;pmid=23034605&amp;doi=10.1038/ajg.2012.79&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Agarwal N, Ollington K, Kaneshiro M, et al. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine. 2012;30:1413–1424.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2011.11.109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22197580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Are%20immunosuppressive%20medications%20associated%20with%20decreased%20responses%20to%20routine%20immunizations?%20A%20systematic%20review&amp;author=N%20Agarwal&amp;author=K%20Ollington&amp;author=M%20Kaneshiro&amp;volume=30&amp;publication_year=2012&amp;pages=1413-1424&amp;pmid=22197580&amp;doi=10.1016/j.vaccine.2011.11.109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Altunöz ME, Senateş E, Yeşil A, et al. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls. Dig Dis Sci. 2012;57:1039–1044.
</cite> [<a href="https://doi.org/10.1007/s10620-011-1980-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22147248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dig%20Dis%20Sci&amp;title=Patients%20with%20inflammatory%20bowel%20disease%20have%20a%20lower%20response%20rate%20to%20HBV%20vaccination%20compared%20to%20controls&amp;author=ME%20Altun%C3%B6z&amp;author=E%20Senate%C5%9F&amp;author=A%20Ye%C5%9Fil&amp;volume=57&amp;publication_year=2012&amp;pages=1039-1044&amp;pmid=22147248&amp;doi=10.1007/s10620-011-1980-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Pratt PK, Jr, Nunes D, Long MT, et al. Improved antibody response to three additional hepatitis B vaccine doses following primary vaccination failure in patients with inflammatory bowel disease. Dig Dis Sci. 2019;64:2031–2038.
</cite> [<a href="https://doi.org/10.1007/s10620-019-05595-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6764090/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30945037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dig%20Dis%20Sci&amp;title=Improved%20antibody%20response%20to%20three%20additional%20hepatitis%20B%20vaccine%20doses%20following%20primary%20vaccination%20failure%20in%20patients%20with%20inflammatory%20bowel%20disease&amp;author=PK%20Pratt&amp;author=D%20Nunes&amp;author=MT%20Long&amp;volume=64&amp;publication_year=2019&amp;pages=2031-2038&amp;pmid=30945037&amp;doi=10.1007/s10620-019-05595-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Gustafson CE, Kim C, Weyand CM, et al. Influence of immune aging on vaccine responses. J Allergy Clin Immunol. 2020;145:1309–1321.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2020.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7198995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32386655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Allergy%20Clin%20Immunol&amp;title=Influence%20of%20immune%20aging%20on%20vaccine%20responses&amp;author=CE%20Gustafson&amp;author=C%20Kim&amp;author=CM%20Weyand&amp;volume=145&amp;publication_year=2020&amp;pages=1309-1321&amp;pmid=32386655&amp;doi=10.1016/j.jaci.2020.03.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Chen J, Deng JC, Goldstein DR. How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions. Trends Mol Med. 2022;28:1100–1111.
</cite> [<a href="https://doi.org/10.1016/j.molmed.2022.09.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9691569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36216643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Mol%20Med&amp;title=How%20aging%20impacts%20vaccine%20efficacy:%20known%20molecular%20and%20cellular%20mechanisms%20and%20future%20directions&amp;author=J%20Chen&amp;author=JC%20Deng&amp;author=DR%20Goldstein&amp;volume=28&amp;publication_year=2022&amp;pages=1100-1111&amp;pmid=36216643&amp;doi=10.1016/j.molmed.2022.09.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35:1368–1375.
</cite> [<a href="https://doi.org/10.1086/344271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12439800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=The%20effect%20of%20age%20on%20immunologic%20response%20to%20recombinant%20hepatitis%20B%20vaccine:%20a%20meta-analysis&amp;author=DN%20Fisman&amp;author=D%20Agrawal&amp;author=K%20Leder&amp;volume=35&amp;publication_year=2002&amp;pages=1368-1375&amp;pmid=12439800&amp;doi=10.1086/344271&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Williams AL. Heplisav-B in prior hepatitis B vaccine nonresponders: a case series. Mil Med. 2022;187:e811–e813.
</cite> [<a href="https://doi.org/10.1093/milmed/usab397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34557923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mil%20Med&amp;title=Heplisav-B%20in%20prior%20hepatitis%20B%20vaccine%20nonresponders:%20a%20case%20series&amp;author=AL%20Williams&amp;volume=187&amp;publication_year=2022&amp;pages=e811-e813&amp;pmid=34557923&amp;doi=10.1093/milmed/usab397&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Khaimova R, Fischetti B, Cope R, et al. Serological response with Heplisav-B in prior hepatitis B vaccine non-responders living with HIV. Vaccine. 2021;39:6529–6534.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2021.09.050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34600748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Serological%20response%20with%20Heplisav-B%20in%20prior%20hepatitis%20B%20vaccine%20non-responders%20living%20with%20HIV&amp;author=R%20Khaimova&amp;author=B%20Fischetti&amp;author=R%20Cope&amp;volume=39&amp;publication_year=2021&amp;pages=6529-6534&amp;pmid=34600748&amp;doi=10.1016/j.vaccine.2021.09.050&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Infect Dis Clin North Am. 2006;20:27–45.
</cite> [<a href="https://doi.org/10.1016/j.idc.2006.01.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16527647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Infect%20Dis%20Clin%20North%20Am&amp;title=Hepatitis%20B%20vaccines&amp;author=AS%20Yu&amp;author=RC%20Cheung&amp;author=EB%20Keeffe&amp;volume=20&amp;publication_year=2006&amp;pages=27-45&amp;pmid=16527647&amp;doi=10.1016/j.idc.2006.01.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Chen J, Liang Z, Lu F, et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine. 2011;29:706–711.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2010.11.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21111021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Toll-like%20receptors%20and%20cytokines/cytokine%20receptors%20polymorphisms%20associate%20with%20non-response%20to%20hepatitis%20B%20vaccine&amp;author=J%20Chen&amp;author=Z%20Liang&amp;author=F%20Lu&amp;volume=29&amp;publication_year=2011&amp;pages=706-711&amp;pmid=21111021&amp;doi=10.1016/j.vaccine.2010.11.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Karime C, Black CN, Cortes P, et al. Utility of a third Heplisav-B dose in patients with inflammatory bowel disease without immunity after 2-dose Heplisav-B vaccination. Am J Gastroenterol. 2024; [Epub ahead of print].</cite> [<a href="https://doi.org/10.14309/ajg.0000000000002863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38717045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Utility%20of%20a%20third%20Heplisav-B%20dose%20in%20patients%20with%20inflammatory%20bowel%20disease%20without%20immunity%20after%202-dose%20Heplisav-B%20vaccination&amp;author=C%20Karime&amp;author=CN%20Black&amp;author=P%20Cortes&amp;publication_year=2024&amp;pmid=38717045&amp;doi=10.14309/ajg.0000000000002863&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Corral JE, Kwon JY, Caldera F, et al. Cost-effectiveness of an adjuvanted hepatitis B vaccine (Heplisav-B) in patients with inflammatory bowel disease. Crohns Colitis 360. 2020;3:otaa090.
</cite> [<a href="https://doi.org/10.1093/crocol/otaa090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9802290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36777070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crohns%20Colitis%20360&amp;title=Cost-effectiveness%20of%20an%20adjuvanted%20hepatitis%20B%20vaccine%20(Heplisav-B)%20in%20patients%20with%20inflammatory%20bowel%20disease&amp;author=JE%20Corral&amp;author=JY%20Kwon&amp;author=F%20Caldera&amp;volume=3&amp;publication_year=2020&amp;pages=otaa090&amp;pmid=36777070&amp;doi=10.1093/crocol/otaa090&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R43">
<span class="label">43.</span><cite>Bruxvoort K, Slezak J, Huang R, et al. Association of number of doses with hepatitis B vaccine series completion in US adults. JAMA Netw Open. 2020;3:e2027577.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2020.27577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7705595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33252692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Association%20of%20number%20of%20doses%20with%20hepatitis%20B%20vaccine%20series%20completion%20in%20US%20adults&amp;author=K%20Bruxvoort&amp;author=J%20Slezak&amp;author=R%20Huang&amp;volume=3&amp;publication_year=2020&amp;pages=e2027577&amp;pmid=33252692&amp;doi=10.1001/jamanetworkopen.2020.27577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>Oster G, Bornheimer R, Ottino K, et al. Adult immunization against hepatitis B: does the number of jabs matter?
Vaccine. 2022;40:3597–3604.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2022.04.080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35570079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Adult%20immunization%20against%20hepatitis%20B:%20does%20the%20number%20of%20jabs%20matter?&amp;author=G%20Oster&amp;author=R%20Bornheimer&amp;author=K%20Ottino&amp;volume=40&amp;publication_year=2022&amp;pages=3597-3604&amp;pmid=35570079&amp;doi=10.1016/j.vaccine.2022.04.080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Clinical Gastroenterology are provided here courtesy of <strong>Wolters Kluwer Health</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1097/MCG.0000000000002098"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/mcg-59-773.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (184.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12329805/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12329805/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12329805%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12329805/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12329805/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12329805/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40424081/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12329805/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40424081/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12329805/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12329805/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="n6WpfVKr2K6vawwHjf56wjY3i7dInOpct8MLue58kPsZzaQWsmGGWnyQsPFMi2ml">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
